Calidi Biotherapeutics Inc
CLDI0.599USD
+0.009+1.44%
交易中 （美東）報價延遲15分鐘
19.04M總市值
虧損本益比TTM
關於 Calidi Biotherapeutics Inc 公司
Calidi Biotherapeutics, Inc. 是一家臨牀階段的免疫腫瘤學公司，其技術旨在武裝免疫系統對抗癌症。該公司的新型幹細胞平臺利用強大的同種異體幹細胞，能夠攜帶溶瘤病毒有效載荷，用於多種腫瘤適應症，包括高級別膠質瘤和實體瘤。其臨牀階段的現成通用細胞遞送平臺旨在保護、擴增和增強溶瘤病毒。其臨牀前現成的包膜病毒療法旨在針對播散性實體瘤。這種雙重方法將有可能治療甚至預防轉移性疾病。其候選產品包括用於複發性 HGG 的 CLD-101、用於晚期實體瘤的 CLD-201 和用於某些肺癌和轉移性實體瘤的 CLD-400 (RTNova)。除其在研產品候選藥物外，該公司還致力於 CLD-301 (AAA) 的多種適應症的發現研究。
公司簡介
公司代碼CLDI
公司名稱Calidi Biotherapeutics Inc
上市日期Sep 10, 2021
CEODr. Eric Poma, Ph.D.
員工數量28
證券類型Ordinary Share
年結日Sep 10
公司地址4475 Executive Drive, Suite 200
城市SAN DIEGO
上市交易所NYSE American Consolidated
國家United States of America
郵編92121
電話18587949600
網址https://www.calidibio.com/
公司代碼CLDI
上市日期Sep 10, 2021
CEODr. Eric Poma, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Scott Leftwich
Mr. Scott Leftwich
Independent Director
Independent Director
259.54K
--
Mr. James A. Schoeneck
Mr. James A. Schoeneck
Independent Chairman of the Board
Independent Chairman of the Board
114.13K
--
Mr. Alan R. Stewart
Mr. Alan R. Stewart
Independent Director
Independent Director
28.98K
--
Ms. Wendy Pizarro Campbell, Esq.
Ms. Wendy Pizarro Campbell, Esq.
Chief Administrative Officer, Chief Legal Officer, Chief Diversity Officer, Corporate Secretary
Chief Administrative Officer, Chief Legal Officer, Chief Diversity Officer, Corporate Secretary
--
--
Mr. Allan J. Camaisa
Mr. Allan J. Camaisa
Independent Director
Independent Director
--
--
Col. (Retd.) George E. Peoples, Jr., M.D.
Col. (Retd.) George E. Peoples, Jr., M.D.
Independent Director
Independent Director
--
--
Mr. Stephen Jasper
Mr. Stephen Jasper
Investor Relations
Investor Relations
--
--
Dr. Eric Poma, Ph.D.
Dr. Eric Poma, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Travis Clifton, M.D.
Dr. Travis Clifton, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Andrew C. Jackson
Mr. Andrew C. Jackson
Chief Financial Officer
Chief Financial Officer
--
-100.00%
名稱
名稱/職務
職務
持股
持股變動
Mr. Scott Leftwich
Mr. Scott Leftwich
Independent Director
Independent Director
259.54K
--
Mr. James A. Schoeneck
Mr. James A. Schoeneck
Independent Chairman of the Board
Independent Chairman of the Board
114.13K
--
Mr. Alan R. Stewart
Mr. Alan R. Stewart
Independent Director
Independent Director
28.98K
--
Ms. Wendy Pizarro Campbell, Esq.
Ms. Wendy Pizarro Campbell, Esq.
Chief Administrative Officer, Chief Legal Officer, Chief Diversity Officer, Corporate Secretary
Chief Administrative Officer, Chief Legal Officer, Chief Diversity Officer, Corporate Secretary
--
--
Mr. Allan J. Camaisa
Mr. Allan J. Camaisa
Independent Director
Independent Director
--
--
Col. (Retd.) George E. Peoples, Jr., M.D.
Col. (Retd.) George E. Peoples, Jr., M.D.
Independent Director
Independent Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 7月2日 週三
更新時間: 7月2日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Armistice Capital LLC
9.62%
Jamir Trust
1.76%
BMO Nesbitt Burns Inc.
1.42%
Kessler (Judd S)
1.08%
The Vanguard Group, Inc.
1.02%
Other
85.09%
持股股東
持股股東
佔比
Armistice Capital LLC
9.62%
Jamir Trust
1.76%
BMO Nesbitt Burns Inc.
1.42%
Kessler (Judd S)
1.08%
The Vanguard Group, Inc.
1.02%
Other
85.09%
股東類型
持股股東
佔比
Hedge Fund
9.77%
Investment Advisor
4.03%
Individual Investor
2.85%
Corporation
2.58%
Investment Advisor/Hedge Fund
1.87%
Research Firm
0.16%
Venture Capital
0.05%
Other
78.69%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
100
7.64M
29.37%
+4.42M
2025Q1
104
7.65M
23.70%
+4.58M
2024Q4
102
3.31M
11.93%
+1.13M
2024Q3
94
2.46M
23.73%
+462.38K
2024Q2
111
2.30M
38.69%
-356.37K
2024Q1
113
2.02M
47.34%
-720.95K
2023Q4
108
2.00M
46.75%
-874.01K
2023Q3
95
1.86M
60.12%
+4.51K
2023Q2
68
377.00K
91.33%
-1.38M
2023Q1
66
400.63K
97.05%
-1.31M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Armistice Capital LLC
3.32M
10.45%
+3.32M
--
Mar 31, 2025
Jamir Trust
608.38K
1.91%
--
--
Jun 20, 2025
BMO Nesbitt Burns Inc.
489.80K
1.54%
+477.30K
+3818.40%
Mar 31, 2025
Kessler (Judd S)
372.98K
1.17%
+372.98K
--
May 01, 2024
The Vanguard Group, Inc.
353.38K
1.11%
+292.01K
+475.78%
Mar 31, 2025
AJC Capital LLC
281.51K
0.89%
--
--
Jun 20, 2025
Leftwich (Scott)
259.54K
0.82%
--
--
Jun 20, 2025
Geode Capital Management, L.L.C.
251.92K
0.79%
+91.90K
+57.43%
Mar 31, 2025
Belpointe Asset Management LLC
249.83K
0.79%
+249.83K
--
Mar 31, 2025
Hightower Advisors, LLC
119.47K
0.38%
+17.20K
+16.81%
Mar 31, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Jul 05, 2024
Merger
10<1
Jul 05, 2024
Merger
10<1
Jul 05, 2024
Merger
10<1
Jul 05, 2024
Merger
10<1
公告日期
類型
比率
Jul 05, 2024
Merger
10<1
Jul 05, 2024
Merger
10<1
Jul 05, 2024
Merger
10<1
Jul 05, 2024
Merger
10<1
